Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06281808
Other study ID # R490
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 28, 2024
Est. completion date December 31, 2026

Study information

Verified date February 2024
Source Balgrist University Hospital
Contact Reto Sutter, MD
Phone 0041443861111
Email reto.sutter@balgrist.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study aims to compare subjective image quality and diagnostic accuracy of a photon counting detector computed tomography (PCD-CT) scanner compared with an energy integrating detector (EID)-CT scanner as the reference standard.


Description:

Computed tomography (CT) imaging plays a key role in diagnostic radiology, and is particularly valuable in assessing a myriad of musculoskeletal conditions (e.g. trauma, degenerative disorders, post-surgical follow-up, inflammatory diseases). The vast majority of today's CT scanners are equipped with an energy-integrating detector (EID), which converts energy of incoming X-ray photons in a two-step process into electric signals: First, scintillators generate visible light, which in turn is converted to the electric signal by photodiodes. Recently, photon-counting detector computed tomography (PCD-CT) scanners became commercially available and have been introduced to improve imaging performance through direct transformation of X-ray photons into electron hole pairs upon absorption in a semiconductor layer, generating an electrical signal proportional to the photon energy. Current literature has shown that PCD-CT can offer higher spatial resolution, increased contrast-to-noise ratio, higher dose-efficiency, and inherent multi-spectral imaging capacity. Moreover, the results from cadaver studies suggest that PCD-CT can preserve image quality with reduced radiation dose. However, data on the diagnostic accuracy of PCD-CT compared to EID-CT is currently limited in the field of musculoskeletal radiology. In addition to conventional CT acquisition, multi-spectral CT imaging in patients with gout and after trauma, is used in clinical routine to delineate materials with a specific absorption coefficient: in gout, urate crystals can be visualized, while after trauma, bone marrow edema can be detected. For EID-CT, different techniques for multi-spectral CT imaging are available (e.g. fast kV switching, dual source CT) which are widely used in clinical routine. Multi-spectral imaging is also inherently available for recently introduced PCD-CT. However, data on diagnostic accuracy of multi-spectral PCD-CT is currently lacking.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date December 31, 2026
Est. primary completion date September 1, 2026
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient admitted for non-contrast enhanced CT scan of the upper or lower extremity at the radiology department of Balgrist University Hospital - Signed general consent ("Information zur Weiterverwendung gesundheitsbezogener Daten und Proben zu Forschungszwecken") - >18 years of age - Written consent to participate in this study Exclusion Criteria: - Clinically significant concomitant disease states (e.g., renal failure, hepatic dysfunction, cardiovascular disease, etc.) - Women: pregnancy - Age below 18 years - Known or suspected non-compliance, drug or alcohol abuse - Inability to consent and/or follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject - Enrolment of the PI, his/her family members, employees and other dependent persons - Body mass above 200 kg. - Body mass below 31 kg.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Photon Counting Detector CT
Photon counting detector CT scan with dose arbitrarily reduced compared to EID CT scan (e.g., half the dose of EID CT)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Reto Sutter, MD

Outcome

Type Measure Description Time frame Safety issue
Primary Image Quality PCD CT Likert scale based - 5 point Likert scale (0 = worst, 5 = best)
Visual gradings of PCD-CT image quality. Image quality will be assessed by teams of experienced musculoskeletal radiologists. Images from consistent sets of intra-subject PCD-CT and EID-CT data will be presented to derive the primary outcome data, in particular using visual analog scales (Likert-Scales). Inter-reader reliability will be assessed.
2 years
Primary Diagnostic Accuracy PCD CT This will involve the calculation of sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy. The EID-CT image interpretation of the attending radiologists, as documented in the written report, will serve as reference standard against which the performance of PCD-CT will be compared. In cases with inconclusive written reports and image findings of EID-CT, a review committee consisting of experienced radiologists (e.g., other attending radiologists, chief of radiology) will be convened, and consensus reading including clinical correlation by consulting with the treating physicians and specialists involved in the patient's care will be done. Diagnostic confidence will be additionally analyzed for PCD-CT scans on a Likert-Scale. Inter-reader reliability will be assessed. 2 years
See also
  Status Clinical Trial Phase
Completed NCT01415414 - Observational Study of Ultravist in Patients Requiring CECT N/A
Terminated NCT00975299 - Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Not yet recruiting NCT05036460 - Real-time Sonography in Detecting Inadvertent Esophageal Intubation Among Difficult Intubation Patients N/A
Recruiting NCT05610098 - Gene Expression Profiles in Spinal Tuberculosis.
Completed NCT01009359 - Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers Phase 1
Completed NCT00244140 - Ultravist: Safety and Efficacy in Computed Tomography of Head and Body Phase 3
Completed NCT02980081 - Abdominal Plain X-ray in the Emergency Departement N/A
Completed NCT01205321 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers Phase 1
Recruiting NCT05823857 - Effect of an Aquatic Exercise Program in Patients With Chronic Low Back Pain N/A
Recruiting NCT04859634 - Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
Completed NCT03125629 - Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals Phase 2
Terminated NCT03167190 - Ultrasound-Assisted Lumbar Puncture N/A
Completed NCT01297088 - PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations. Phase 1
Completed NCT01089998 - PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations Phase 1
Completed NCT00347022 - A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications Phase 4
Completed NCT00876083 - PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination N/A
Completed NCT01411449 - Primovist Post-marketing Surveillance in Japan N/A
Completed NCT01153607 - Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers Phase 1
Completed NCT00709852 - Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging Phase 3
Terminated NCT00659776 - MR, Histologic And EM Imaging Of Intravenous Ferumoxytol In Central Nervous System (CNS) Inflammation Phase 2